Trade flows remain balanced at roughly $48 billion in imports and $49 billion in exports, yet 91% of biologics sold domestically are imported, revealing a paradox: America manufactures heavily but ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...
Savara Inc. (the "Company"), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and participate in ...
Translation factors eIF1A and eIF5B are key repressors of an abnormal protein translation process linked to neurodegenerative ...
Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...
Next-Generation Biopharmaceuticals Transforming the Global Therapeutic LandscapeThe Global Bio Pharmaceuticals Market is ...
ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today ...
For nearly 30 years, 4Life has led the way in immune system innovation, developing science-backed nutraceuticals that help ...
Dear D.M.: FVL is an inherited genetic condition that somewhat predisposes people to excess blood clotting. It is very common ...
The global population is ageing and this demographic shift has profound effects on haemostasis, notably a progressive tilt ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback